Cargando…

Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST

BACKGROUND: The prediction model of intravenous immunoglobulin (IVIG) resistance in Kawasaki disease can calculate the probability of IVIG resistance and provide a basis for clinical decision-making. We aim to assess the quality of these models developed in the children with Kawasaki disease. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuhui, Huang, Hongbiao, Hou, Miao, Xu, Qiuqin, Qian, Weiguo, Tang, Yunjia, Li, Xuan, Qian, Guanghui, Ma, Jin, Zheng, Yiming, Shen, Yueping, Lv, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444619/
https://www.ncbi.nlm.nih.gov/pubmed/36964445
http://dx.doi.org/10.1038/s41390-023-02558-6
_version_ 1785093988291706880
author Wang, Shuhui
Huang, Hongbiao
Hou, Miao
Xu, Qiuqin
Qian, Weiguo
Tang, Yunjia
Li, Xuan
Qian, Guanghui
Ma, Jin
Zheng, Yiming
Shen, Yueping
Lv, Haitao
author_facet Wang, Shuhui
Huang, Hongbiao
Hou, Miao
Xu, Qiuqin
Qian, Weiguo
Tang, Yunjia
Li, Xuan
Qian, Guanghui
Ma, Jin
Zheng, Yiming
Shen, Yueping
Lv, Haitao
author_sort Wang, Shuhui
collection PubMed
description BACKGROUND: The prediction model of intravenous immunoglobulin (IVIG) resistance in Kawasaki disease can calculate the probability of IVIG resistance and provide a basis for clinical decision-making. We aim to assess the quality of these models developed in the children with Kawasaki disease. METHODS: Studies of prediction models for IVIG-resistant Kawasaki disease were identified through searches in the PubMed, Web of Science, and Embase databases. Two investigators independently performed literature screening, data extraction, quality evaluation, and discrepancies were settled by a statistician. The checklist for critical appraisal and data extraction for systematic reviews of prediction modeling studies (CHARMS) was used for data extraction, and the prediction models were evaluated using the Prediction Model Risk of Bias Assessment Tool (PROBAST). RESULTS: Seventeen studies meeting the selection criteria were included in the qualitative analysis. The top three predictors were neutrophil measurements (peripheral neutrophil count and neutrophil %), serum albumin level, and C-reactive protein (CRP) level. The reported area under the curve (AUC) values for the developed models ranged from 0.672 (95% confidence interval [CI]: 0.631–0.712) to 0.891 (95% CI: 0.837–0.945); The studies showed a high risk of bias (ROB) for modeling techniques, yielding a high overall ROB. CONCLUSION: IVIG resistance models for Kawasaki disease showed high ROB. An emphasis on improving their quality can provide high-quality evidence for clinical practice. IMPACT STATEMENT: This study systematically evaluated the risk of bias (ROB) of existing prediction models for intravenous immunoglobulin (IVIG) resistance in Kawasaki disease to provide guidance for future model development meeting clinical expectations. This is the first study to systematically evaluate the ROB of IVIG resistance in Kawasaki disease by using PROBAST. ROB may reduce model performance in different populations. Future prediction models should account for this problem, and PROBAST can help improve the methodological quality and applicability of prediction model development.
format Online
Article
Text
id pubmed-10444619
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-104446192023-08-24 Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST Wang, Shuhui Huang, Hongbiao Hou, Miao Xu, Qiuqin Qian, Weiguo Tang, Yunjia Li, Xuan Qian, Guanghui Ma, Jin Zheng, Yiming Shen, Yueping Lv, Haitao Pediatr Res Clinical Research Article BACKGROUND: The prediction model of intravenous immunoglobulin (IVIG) resistance in Kawasaki disease can calculate the probability of IVIG resistance and provide a basis for clinical decision-making. We aim to assess the quality of these models developed in the children with Kawasaki disease. METHODS: Studies of prediction models for IVIG-resistant Kawasaki disease were identified through searches in the PubMed, Web of Science, and Embase databases. Two investigators independently performed literature screening, data extraction, quality evaluation, and discrepancies were settled by a statistician. The checklist for critical appraisal and data extraction for systematic reviews of prediction modeling studies (CHARMS) was used for data extraction, and the prediction models were evaluated using the Prediction Model Risk of Bias Assessment Tool (PROBAST). RESULTS: Seventeen studies meeting the selection criteria were included in the qualitative analysis. The top three predictors were neutrophil measurements (peripheral neutrophil count and neutrophil %), serum albumin level, and C-reactive protein (CRP) level. The reported area under the curve (AUC) values for the developed models ranged from 0.672 (95% confidence interval [CI]: 0.631–0.712) to 0.891 (95% CI: 0.837–0.945); The studies showed a high risk of bias (ROB) for modeling techniques, yielding a high overall ROB. CONCLUSION: IVIG resistance models for Kawasaki disease showed high ROB. An emphasis on improving their quality can provide high-quality evidence for clinical practice. IMPACT STATEMENT: This study systematically evaluated the risk of bias (ROB) of existing prediction models for intravenous immunoglobulin (IVIG) resistance in Kawasaki disease to provide guidance for future model development meeting clinical expectations. This is the first study to systematically evaluate the ROB of IVIG resistance in Kawasaki disease by using PROBAST. ROB may reduce model performance in different populations. Future prediction models should account for this problem, and PROBAST can help improve the methodological quality and applicability of prediction model development. Nature Publishing Group US 2023-03-24 2023 /pmc/articles/PMC10444619/ /pubmed/36964445 http://dx.doi.org/10.1038/s41390-023-02558-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Clinical Research Article
Wang, Shuhui
Huang, Hongbiao
Hou, Miao
Xu, Qiuqin
Qian, Weiguo
Tang, Yunjia
Li, Xuan
Qian, Guanghui
Ma, Jin
Zheng, Yiming
Shen, Yueping
Lv, Haitao
Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST
title Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST
title_full Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST
title_fullStr Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST
title_full_unstemmed Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST
title_short Risk-prediction models for intravenous immunoglobulin resistance in Kawasaki disease: Risk-of-Bias Assessment using PROBAST
title_sort risk-prediction models for intravenous immunoglobulin resistance in kawasaki disease: risk-of-bias assessment using probast
topic Clinical Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444619/
https://www.ncbi.nlm.nih.gov/pubmed/36964445
http://dx.doi.org/10.1038/s41390-023-02558-6
work_keys_str_mv AT wangshuhui riskpredictionmodelsforintravenousimmunoglobulinresistanceinkawasakidiseaseriskofbiasassessmentusingprobast
AT huanghongbiao riskpredictionmodelsforintravenousimmunoglobulinresistanceinkawasakidiseaseriskofbiasassessmentusingprobast
AT houmiao riskpredictionmodelsforintravenousimmunoglobulinresistanceinkawasakidiseaseriskofbiasassessmentusingprobast
AT xuqiuqin riskpredictionmodelsforintravenousimmunoglobulinresistanceinkawasakidiseaseriskofbiasassessmentusingprobast
AT qianweiguo riskpredictionmodelsforintravenousimmunoglobulinresistanceinkawasakidiseaseriskofbiasassessmentusingprobast
AT tangyunjia riskpredictionmodelsforintravenousimmunoglobulinresistanceinkawasakidiseaseriskofbiasassessmentusingprobast
AT lixuan riskpredictionmodelsforintravenousimmunoglobulinresistanceinkawasakidiseaseriskofbiasassessmentusingprobast
AT qianguanghui riskpredictionmodelsforintravenousimmunoglobulinresistanceinkawasakidiseaseriskofbiasassessmentusingprobast
AT majin riskpredictionmodelsforintravenousimmunoglobulinresistanceinkawasakidiseaseriskofbiasassessmentusingprobast
AT zhengyiming riskpredictionmodelsforintravenousimmunoglobulinresistanceinkawasakidiseaseriskofbiasassessmentusingprobast
AT shenyueping riskpredictionmodelsforintravenousimmunoglobulinresistanceinkawasakidiseaseriskofbiasassessmentusingprobast
AT lvhaitao riskpredictionmodelsforintravenousimmunoglobulinresistanceinkawasakidiseaseriskofbiasassessmentusingprobast